Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review

Máñez-Miró JU, Rodríguez-Rojas R, Del Álamo M, Martínez-Fernández R, Obeso JA.

Expert Rev Neurother. 2021 May;21(5):533-545. doi: 10.1080/14737175.2021.1911649. Epub 2021 May 6.

Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases

Kulenkampff K, Wolf Perez AM, Sormanni P, Habchi J, Vendruscolo M.

Nat Rev Chem. 2021 Apr;5(4):277-294. doi: 10.1038/s41570-021-00254-9. Epub 2021 Feb 15.

Prognostic predictors relevant to end-of-life palliative care in Parkinson's disease and related disorders: a systematic review

Akbar U, McQueen RB, Bemski J, Carter J, Goy ER, Kutner J, Johnson MJ, Miyasaki JM, Kluger B.

J Neurol Neurosurg Psychiatry. 2021 Mar 31;92(6):629-36. doi: 10.1136/jnnp-2020-323939. Online ahead of print.

Association of Physical Activity and APOE Genotype With Longitudinal Cognitive Change in Early Parkinson Disease

Kim R, Park S, Yoo D, Jun JS, Jeon B.

Neurology. 2021 May 11;96(19):e2429-e2437. doi: 10.1212/WNL.0000000000011852. Epub 2021 Mar 31.

Physical Activity May Reduce Apolipoprotein E4-Associated Cognitive Decline in Parkinson Disease

Raber J, Darweesh SKL, Savica R.

Neurology. 2021 May 11;96(19):877-878. doi: 10.1212/WNL.0000000000011851. Epub 2021 Mar 31.

Impulse Control Disorders in Parkinson's Disease: From Bench to Bedside

Augustine A, Winstanley CA, Krishnan V.

Front Neurosci. 2021 Mar 12;15:654238. doi: 10.3389/fnins.2021.654238. eCollection 2021.

Membrane Interactions and Toxicity by Misfolded Protein Oligomers

Gonzalez-Garcia M, Fusco G, De Simone A.

Front Cell Dev Biol. 2021 Mar 11;9:642623. doi: 10.3389/fcell.2021.642623. eCollection 2021.

Biofeedback-Based Connected Mental Health Interventions for Anxiety: Systematic Literature Review

Alneyadi M, Drissi N, Almeqbaali M, Ouhbi S.

JMIR Mhealth Uhealth. 2021 Apr 22;9(4):e26038. doi: 10.2196/26038.

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial

Rascol O, Cochen de Cock V, Pavy-Le Traon A, Foubert-Samier A, Thalamas C, Sommet A, Rousseau V, Perez-Lloret S, Fabbri M, Azulay JP, Corvol JC, Couratier P, Damier P, Defebvre L, Durif F, Geny C, Houeto JL, Remy P, Tranchant C, Verin M, Tison F, Meissner WG; MSA-FLUO Study Group.

Mov Disord. 2021 Jul;36(7):1704-1711. doi: 10.1002/mds.28569. Epub 2021 Apr 1.

Diagnosis and cure of supraventricular tachycardia

Morady F.

Heart Rhythm. 2021 Apr;18(4):651-652. doi: 10.1016/j.hrthm.2020.11.010.

Unraveling the Link Between Mitochondrial Dynamics and Neuroinflammation

de Oliveira LG, Angelo YS, Iglesias AH, Peron JPS.

Front Immunol. 2021 Mar 16;12:624919. doi: 10.3389/fimmu.2021.624919. eCollection 2021.

Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta-Analysis

Nijhuis FAP, Esselink R, de Bie RMA, Groenewoud H, Bloem BR, Post B, Meinders MJ.

Mov Disord. 2021 Jun;36(6):1293-1307. doi: 10.1002/mds.28599. Epub 2021 Apr 2.

Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies

Ma L, Gholam Azad M, Dharmasivam M, Richardson V, Quinn RJ, Feng Y, Pountney DL, Tonissen KF, Mellick GD, Yanatori I, Richardson DR.

Redox Biol. 2021 May;41:101896. doi: 10.1016/j.redox.2021.101896. Epub 2021 Feb 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias